Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

Competitive Landscape Major players in the GI Endoscopic Devices Market include Olympus, Boston Scientific, Pentax (Hoya), ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

WASHINGTON (AP) — As the government shutdown stretches on, military advocates are warning of long-lasting effects to National ...

The latest update is out from Oncolytics Biotech ( (ONCY) ).

ATLANTA -- An investigational quadruple receptor agonist led to a substantial reduction in total body weight with minimal ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals, ...

Discover advanced digestive health services at Baylor Scott & White Medical Center – Frisco at PGA Parkway, offering expert GI care close to home.

This father appeared to have a seizure after a U.S. Immigration and Customs Enforcement (ICE) agent grabbed him by the neck ...

Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

Discover advanced digestive health services at Baylor Scott & White Medical Center – Frisco at PGA Parkway, offering expert ...